Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

Google DeepMind's spinoff Isomorphic Labs is set to begin human trials of a drug desinged completely by Artificial Intelligence.

Alphabet’s AI-powered drug discovery company, Isomorphic Labs, is preparing to take its first major leap into the real world.

Isomorphic Labs advances towards human clinical trials for AI-designed drugs, marking a pivotal moment in pharmaceutical ...

Bill Gates has warned that AI will replace many jobs, but says coding will stay a fully human profession, even hundreds of ...

Microsoft's new model-agnostic MAI Diagnostic Orchestrator (MAI-DxO) achieved 85.5 percent diagnostic accuracy—outperforming ...

At the forefront of technological innovation, Google DeepMind has embarked on a transformative journey, one that blurs the line between artificial intelligence and robotics. This marked a ...

Mumbai-based ARMMAN, with Google DeepMind's AI support, enhances maternal health programs Kilkari and mMitra, showing promising results across India. Kilkari uses AI to optimize call times ...

Mohamed bin Zayed University for Artificial Intelligence has unveiled a pioneering embodied‐AI framework called Tactile Skills, enabling robots to ...